CDH1 and non-small cell lung carcinoma: With respect to EMT, both NSCLC cells lines that received sorafenib along with dauricine exhibited considerable rise in E-cadherin, a hallmark of the epithelial-mesenchymal transition (EMT), in comparison to control groups and sorafenib or dauricine groups alone.